APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Prenatal Second-Generation DNA Sequencing

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Prenatal Second-Generation DNA Sequencing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174220010311 April 2026190 pages

Choose your research edition.

Industry ResearchPrenatal Second-Generation DNA Sequencing Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Prenatal Second-Generation DNA Sequencing Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Prenatal Second-Generation DNA Sequencing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Prenatal Second-Generation DNA Sequencing Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Prenatal Second-Generation DNA Sequencing Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

The global Prenatal Second-Generation DNA Sequencing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Prenatal Second-Generation DNA Sequencing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Prenatal Second-Generation DNA Sequencing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Prenatal Second-Generation DNA Sequencing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Prenatal Second-Generation DNA Sequencing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Prenatal Second-Generation DNA Sequencing include Natera, Labcorp, Quest Diagnostics, MedGenome, Mayo Clinic Laboratories, GeneDx, PreventionGenetics, SYNLAB and Myriad Genetics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Prenatal Second-Generation DNA Sequencing market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Prenatal Second-Generation DNA Sequencing and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Prenatal Second-Generation DNA Sequencing revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Prenatal Second-Generation DNA Sequencing market size, projected growth trends, production technologies, key applications, and end-use industries.

Prenatal Second-Generation DNA Sequencing Segment by Company

Natera

Labcorp

Quest Diagnostics

MedGenome

Mayo Clinic Laboratories

GeneDx

PreventionGenetics

SYNLAB

Myriad Genetics

GGA

Fulgent Genetics

Rainbow Genomics

BillionToOne

BGI Genomics

Berry Genomics

Annaroad

Weihansi Biomedical Technology

Prenatal Second-Generation DNA Sequencing Segment by Type

Targeted Panels

Exome Sequencing

Others

Prenatal Second-Generation DNA Sequencing Segment by Application

Public Hospitals

Private Hospitals

Prenatal Second-Generation DNA Sequencing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prenatal Second-Generation DNA Sequencing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Prenatal Second-Generation DNA Sequencing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prenatal Second-Generation DNA Sequencing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Prenatal Second-Generation DNA Sequencing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Prenatal Second-Generation DNA Sequencing industry.

Chapter 3: Detailed analysis of Prenatal Second-Generation DNA Sequencing companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Prenatal Second-Generation DNA Sequencingrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Prenatal Second-Generation DNA Sequencing Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Targeted Panels Table 3. Key Players of Exome Sequencing Table 4. Key Players of Others Table 4. Global Prenatal Second-Generation DNA Sequencing Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Public Hospitals Table 6. Key Players of Private Hospitals Table 7. Global Prenatal Second-Generation DNA Sequencing Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 8. Global Prenatal Second-Generation DNA Sequencing Market Size by Region (2021-2026) & (US$ Million) Table 9. Global Prenatal Second-Generation DNA Sequencing Market Share by Region (2021-2026) Table 10. Global Prenatal Second-Generation DNA Sequencing Market Size by Region (2027-2032) & (US$ Million) Table 11. Global Prenatal Second-Generation DNA Sequencing Market Share by Region (2027-2032) Table 12. Prenatal Second-Generation DNA Sequencing Industry Trends Table 13. Prenatal Second-Generation DNA Sequencing Industry Drivers Table 14. Prenatal Second-Generation DNA Sequencing Industry Opportunities and Challenges Table 15. Prenatal Second-Generation DNA Sequencing Industry Restraints Table 16. Global Prenatal Second-Generation DNA Sequencing Revenue by Company (US$ Million) & (2021-2026) Table 17. Global Prenatal Second-Generation DNA Sequencing Revenue Market Share by Company (2021-2026) Table 18. Global Prenatal Second-Generation DNA Sequencing Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 19. Global Prenatal Second-Generation DNA Sequencing Key Company Head Office and Area Served Table 20. Global Prenatal Second-Generation DNA Sequencing Company, Product Type & Application Table 21. Global Prenatal Second-Generation DNA Sequencing Company Establishment Date Table 22. Global Company Market Concentration Ratio (CR5 and HHI) Table 23. Global Prenatal Second-Generation DNA Sequencing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 24. Global Prenatal Second-Generation DNA Sequencing Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Prenatal Second-Generation DNA Sequencing Market Size by Type (2021-2026) & (US$ Million) Table 26. Global Prenatal Second-Generation DNA Sequencing Market Size by Type (2027-2032) & (US$ Million) Table 27. Global Prenatal Second-Generation DNA Sequencing Revenue Market Share by Type (2021-2026) Table 28. Global Prenatal Second-Generation DNA Sequencing Revenue Market Share by Type (2027-2032) Table 29. Global Prenatal Second-Generation DNA Sequencing Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Prenatal Second-Generation DNA Sequencing Market Size by Application (2021-2026) & (US$ Million) Table 31. Global Prenatal Second-Generation DNA Sequencing Market Size by Application (2027-2032) & (US$ Million) Table 32. Global Prenatal Second-Generation DNA Sequencing Revenue Market Share by Application (2021-2026) Table 33. Global Prenatal Second-Generation DNA Sequencing Revenue Market Share by Application (2027-2032) Table 34. Natera Company Information Table 35. Natera Business Overview Table 36. Natera Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. Natera Prenatal Second-Generation DNA Sequencing Product Portfolio Table 38. Natera Recent Development Table 39. Labcorp Company Information Table 40. Labcorp Business Overview Table 41. Labcorp Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Labcorp Prenatal Second-Generation DNA Sequencing Product Portfolio Table 43. Labcorp Recent Development Table 44. Quest Diagnostics Company Information Table 45. Quest Diagnostics Business Overview Table 46. Quest Diagnostics Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Quest Diagnostics Prenatal Second-Generation DNA Sequencing Product Portfolio Table 48. Quest Diagnostics Recent Development Table 49. MedGenome Company Information Table 50. MedGenome Business Overview Table 51. MedGenome Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. MedGenome Prenatal Second-Generation DNA Sequencing Product Portfolio Table 53. MedGenome Recent Development Table 54. Mayo Clinic Laboratories Company Information Table 55. Mayo Clinic Laboratories Business Overview Table 56. Mayo Clinic Laboratories Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Mayo Clinic Laboratories Prenatal Second-Generation DNA Sequencing Product Portfolio Table 58. Mayo Clinic Laboratories Recent Development Table 59. GeneDx Company Information Table 60. GeneDx Business Overview Table 61. GeneDx Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. GeneDx Prenatal Second-Generation DNA Sequencing Product Portfolio Table 63. GeneDx Recent Development Table 64. PreventionGenetics Company Information Table 65. PreventionGenetics Business Overview Table 66. PreventionGenetics Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. PreventionGenetics Prenatal Second-Generation DNA Sequencing Product Portfolio Table 68. PreventionGenetics Recent Development Table 69. SYNLAB Company Information Table 70. SYNLAB Business Overview Table 71. SYNLAB Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. SYNLAB Prenatal Second-Generation DNA Sequencing Product Portfolio Table 73. SYNLAB Recent Development Table 74. Myriad Genetics Company Information Table 75. Myriad Genetics Business Overview Table 76. Myriad Genetics Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. Myriad Genetics Prenatal Second-Generation DNA Sequencing Product Portfolio Table 78. Myriad Genetics Recent Development Table 79. GGA Company Information Table 80. GGA Business Overview Table 81. GGA Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. GGA Prenatal Second-Generation DNA Sequencing Product Portfolio Table 83. GGA Recent Development Table 84. Fulgent Genetics Company Information Table 85. Fulgent Genetics Business Overview Table 86. Fulgent Genetics Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 87. Fulgent Genetics Prenatal Second-Generation DNA Sequencing Product Portfolio Table 88. Fulgent Genetics Recent Development Table 89. Rainbow Genomics Company Information Table 90. Rainbow Genomics Business Overview Table 91. Rainbow Genomics Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 92. Rainbow Genomics Prenatal Second-Generation DNA Sequencing Product Portfolio Table 93. Rainbow Genomics Recent Development Table 94. BillionToOne Company Information Table 95. BillionToOne Business Overview Table 96. BillionToOne Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 97. BillionToOne Prenatal Second-Generation DNA Sequencing Product Portfolio Table 98. BillionToOne Recent Development Table 99. BGI Genomics Company Information Table 100. BGI Genomics Business Overview Table 101. BGI Genomics Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 102. BGI Genomics Prenatal Second-Generation DNA Sequencing Product Portfolio Table 103. BGI Genomics Recent Development Table 104. Berry Genomics Company Information Table 105. Berry Genomics Business Overview Table 106. Berry Genomics Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 107. Berry Genomics Prenatal Second-Generation DNA Sequencing Product Portfolio Table 108. Berry Genomics Recent Development Table 109. Annaroad Company Information Table 110. Annaroad Business Overview Table 111. Annaroad Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 112. Annaroad Prenatal Second-Generation DNA Sequencing Product Portfolio Table 113. Annaroad Recent Development Table 114. Weihansi Biomedical Technology Company Information Table 115. Weihansi Biomedical Technology Business Overview Table 116. Weihansi Biomedical Technology Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 117. Weihansi Biomedical Technology Prenatal Second-Generation DNA Sequencing Product Portfolio Table 118. Weihansi Biomedical Technology Recent Development Table 119. North America Prenatal Second-Generation DNA Sequencing Market Size by Type (2021-2026) & (US$ Million) Table 120. North America Prenatal Second-Generation DNA Sequencing Market Size by Type (2027-2032) & (US$ Million) Table 121. North America Prenatal Second-Generation DNA Sequencing Market Size by Application (2021-2026) & (US$ Million) Table 122. North America Prenatal Second-Generation DNA Sequencing Market Size by Application (2027-2032) & (US$ Million) Table 123. North America Prenatal Second-Generation DNA Sequencing Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 124. North America Prenatal Second-Generation DNA Sequencing Market Size by Country (2021-2026) Table 125. North America Prenatal Second-Generation DNA Sequencing Market Size by Country (2027-2032) Table 126. Europe Prenatal Second-Generation DNA Sequencing Market Size by Type (2021-2026) & (US$ Million) Table 127. Europe Prenatal Second-Generation DNA Sequencing Market Size by Type (2027-2032) & (US$ Million) Table 128. Europe Prenatal Second-Generation DNA Sequencing Market Size by Application (2021-2026) & (US$ Million) Table 129. Europe Prenatal Second-Generation DNA Sequencing Market Size by Application (2027-2032) & (US$ Million) Table 130. Europe Prenatal Second-Generation DNA Sequencing Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 131. Europe Prenatal Second-Generation DNA Sequencing Market Size by Country (2021-2026) Table 132. Europe Prenatal Second-Generation DNA Sequencing Market Size by Country (2027-2032) Table 133. China Prenatal Second-Generation DNA Sequencing Market Size by Type (2021-2026) & (US$ Million) Table 134. China Prenatal Second-Generation DNA Sequencing Market Size by Type (2027-2032) & (US$ Million) Table 135. China Prenatal Second-Generation DNA Sequencing Market Size by Application (2021-2026) & (US$ Million) Table 136. China Prenatal Second-Generation DNA Sequencing Market Size by Application (2027-2032) & (US$ Million) Table 137. Asia Prenatal Second-Generation DNA Sequencing Market Size by Type (2021-2026) & (US$ Million) Table 138. Asia Prenatal Second-Generation DNA Sequencing Market Size by Type (2027-2032) & (US$ Million) Table 139. Asia Prenatal Second-Generation DNA Sequencing Market Size by Application (2021-2026) & (US$ Million) Table 140. Asia Prenatal Second-Generation DNA Sequencing Market Size by Application (2027-2032) & (US$ Million) Table 141. Asia Prenatal Second-Generation DNA Sequencing Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 142. Asia Prenatal Second-Generation DNA Sequencing Market Size by Country (2021-2026) Table 143. Asia Prenatal Second-Generation DNA Sequencing Market Size by Country (2027-2032) Table 144. South America, Middle East & Africa Prenatal Second-Generation DNA Sequencing Market Size by Type (2021-2026) & (US$ Million) Table 145. South America, Middle East & Africa Prenatal Second-Generation DNA Sequencing Market Size by Type (2027-2032) & (US$ Million) Table 146. South America, Middle East & Africa Prenatal Second-Generation DNA Sequencing Market Size by Application (2021-2026) & (US$ Million) Table 147. South America, Middle East & Africa Prenatal Second-Generation DNA Sequencing Market Size by Application (2027-2032) & (US$ Million) Table 148. South America, Middle East & Africa Prenatal Second-Generation DNA Sequencing Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 149. South America, Middle East & Africa Prenatal Second-Generation DNA Sequencing Market Size by Country (2021-2026) Table 150. South America, Middle East & Africa Prenatal Second-Generation DNA Sequencing Market Size by Country (2027-2032) Table 151. Research Programs/Design for This Report Table 152. Authors List of This Report Table 153. Secondary Sources Table 154. Primary Sources List of Figures Figure 1. Prenatal Second-Generation DNA Sequencing Product Image Figure 2. Global Prenatal Second-Generation DNA Sequencing Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Prenatal Second-Generation DNA Sequencing Market Share by Type: 2025 VS 2032 Figure 4. Targeted Panels Image Figure 5. Exome Sequencing Image Figure 6. Others Image Figure 7. Global Prenatal Second-Generation DNA Sequencing Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global Prenatal Second-Generation DNA Sequencing Market Share by Application: 2025 VS 2032 Figure 9. Public Hospitals Image Figure 10. Private Hospitals Image Figure 11. Global Prenatal Second-Generation DNA Sequencing Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Prenatal Second-Generation DNA Sequencing Market Size (2021-2032) & (US$ Million) Figure 13. Global Prenatal Second-Generation DNA Sequencing Market Share by Region: 2025 VS 2032 Figure 14. Years Considered Figure 15. Global Prenatal Second-Generation DNA Sequencing Market Share by Players in 2025 Figure 16. Global Top 5 and 10 Prenatal Second-Generation DNA Sequencing Players Market Share by Revenue in 2025 Figure 17. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Prenatal Second-Generation DNA Sequencing Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Prenatal Second-Generation DNA Sequencing Revenue Market Share by Type (2021-2032) Figure 20. Global Prenatal Second-Generation DNA Sequencing Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Prenatal Second-Generation DNA Sequencing Revenue Market Share by Application (2021-2032) Figure 22. North America Prenatal Second-Generation DNA Sequencing Market Size (2021-2032) & (US$ Million) Figure 23. North America Prenatal Second-Generation DNA Sequencing Market Share by Type (2021-2032) Figure 24. North America Prenatal Second-Generation DNA Sequencing Market Share by Application (2021-2032) Figure 25. North America Prenatal Second-Generation DNA Sequencing Market Share by Country (2021-2032) Figure 26. United States Prenatal Second-Generation DNA Sequencing Market Size (2021-2032) & (US$ Million) Figure 27. Canada Prenatal Second-Generation DNA Sequencing Market Size (2021-2032) & (US$ Million) Figure 28. Mexico Prenatal Second-Generation DNA Sequencing Market Size (2021-2032) & (US$ Million) Figure 29. Europe Prenatal Second-Generation DNA Sequencing Market Size (2021-2032) & (US$ Million) Figure 30. Europe Prenatal Second-Generation DNA Sequencing Market Share by Type (2021-2032) Figure 31. Europe Prenatal Second-Generation DNA Sequencing Market Share by Application (2021-2032) Figure 32. Europe Prenatal Second-Generation DNA Sequencing Market Share by Country (2021-2032) Figure 33. Germany Prenatal Second-Generation DNA Sequencing Market Size (2021-2032) & (US$ Million) Figure 34. France Prenatal Second-Generation DNA Sequencing Market Size (2021-2032) & (US$ Million) Figure 35. U.K. Prenatal Second-Generation DNA Sequencing Market Size (2021-2032) & (US$ Million) Figure 36. Italy Prenatal Second-Generation DNA Sequencing Market Size (2021-2032) & (US$ Million) Figure 37. Russia Prenatal Second-Generation DNA Sequencing Market Size (2021-2032) & (US$ Million) Figure 38. Nordic Countries Prenatal Second-Generation DNA Sequencing Market Size (2021-2032) & (US$ Million) Figure 39. China Prenatal Second-Generation DNA Sequencing Market Size (2021-2032) & (US$ Million) Figure 40. China Prenatal Second-Generation DNA Sequencing Market Share by Type (2021-2032) Figure 41. China Prenatal Second-Generation DNA Sequencing Market Share by Application (2021-2032) Figure 42. Asia Prenatal Second-Generation DNA Sequencing Market Size (2021-2032) & (US$ Million) Figure 43. Asia Prenatal Second-Generation DNA Sequencing Market Share by Type (2021-2032) Figure 44. Asia Prenatal Second-Generation DNA Sequencing Market Share by Application (2021-2032) Figure 45. Asia Prenatal Second-Generation DNA Sequencing Market Share by Country (2021-2032) Figure 46. Japan Prenatal Second-Generation DNA Sequencing Market Size (2021-2032) & (US$ Million) Figure 47. South Korea Prenatal Second-Generation DNA Sequencing Market Size (2021-2032) & (US$ Million) Figure 48. Taiwan Prenatal Second-Generation DNA Sequencing Market Size (2021-2032) & (US$ Million) Figure 49. Southeast Asia Prenatal Second-Generation DNA Sequencing Market Size (2021-2032) & (US$ Million) Figure 50. India Prenatal Second-Generation DNA Sequencing Market Size (2021-2032) & (US$ Million) Figure 51. Australia Prenatal Second-Generation DNA Sequencing Market Size (2021-2032) & (US$ Million) Figure 52. South America, Middle East & Africa Prenatal Second-Generation DNA Sequencing Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Prenatal Second-Generation DNA Sequencing Market Share by Type (2021-2032) Figure 54. South America, Middle East & Africa Prenatal Second-Generation DNA Sequencing Market Share by Application (2021-2032) Figure 55. South America, Middle East & Africa Prenatal Second-Generation DNA Sequencing Market Share by Country (2021-2032) Figure 56. Brazil Prenatal Second-Generation DNA Sequencing Market Size (2021-2032) & (US$ Million) Figure 57. South Africa Prenatal Second-Generation DNA Sequencing Market Size (2021-2032) & (US$ Million) Figure 58. Saudi Arabia Prenatal Second-Generation DNA Sequencing Market Size (2021-2032) & (US$ Million) Figure 59. Turkey Prenatal Second-Generation DNA Sequencing Market Size (2021-2032) & (US$ Million) Figure 60. Argentina Prenatal Second-Generation DNA Sequencing Market Size (2021-2032) & (US$ Million) Figure 61. UAE Prenatal Second-Generation DNA Sequencing Market Size (2021-2032) & (US$ Million) Figure 62. Egypt Prenatal Second-Generation DNA Sequencing Market Size (2021-2032) & (US$ Million) Figure 63. Chile Prenatal Second-Generation DNA Sequencing Market Size (2021-2032) & (US$ Million) Figure 64. Research Process Figure 65. Key Executives Interviewed

Scope & coverage.

Types
  • Targeted Panels
  • Exome Sequencing
  • Others
Applications
  • Public Hospitals
  • Private Hospitals
Companies covered
  • Natera
  • Labcorp
  • Quest Diagnostics
  • MedGenome
  • Mayo Clinic Laboratories
  • GeneDx
  • PreventionGenetics
  • SYNLAB
  • Myriad Genetics
  • GGA
  • Fulgent Genetics
  • Rainbow Genomics
  • BillionToOne
  • BGI Genomics
  • Berry Genomics
  • Annaroad
  • Weihansi Biomedical Technology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Prenatal Second-Generation DNA Sequencing Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Targeted Panels
  5. 1.2.3 Exome Sequencing
  6. 1.2.4 Others
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global Prenatal Second-Generation DNA Sequencing Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 Public Hospitals
  10. 1.3.3 Private Hospitals
  11. 1.4 Global Market Growth Prospects
  12. 1.5 Global Prenatal Second-Generation DNA Sequencing Growth Trends by Region
  13. 1.5.1 Global Prenatal Second-Generation DNA Sequencing Market Size by Region: 2021 VS 2025 VS 2032
  14. 1.5.2 Prenatal Second-Generation DNA Sequencing Market Size by Region (2021-2026)
  15. 1.5.3 Prenatal Second-Generation DNA Sequencing Market Size by Region (2027-2032)
  16. 1.6 Assumptions and Limitations
  17. 1.7 Study Goals and Objectives
  18. 1.8 Years Considered
2 Global Prenatal Second-Generation DNA Sequencing Market Dynamics
  1. 2.1 Prenatal Second-Generation DNA Sequencing Industry Trends
  2. 2.2 Prenatal Second-Generation DNA Sequencing Industry Drivers
  3. 2.3 Prenatal Second-Generation DNA Sequencing Industry Opportunities and Challenges
  4. 2.4 Prenatal Second-Generation DNA Sequencing Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Prenatal Second-Generation DNA Sequencing Revenue by Company (2021-2026)
  2. 3.2 Global Prenatal Second-Generation DNA Sequencing Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Prenatal Second-Generation DNA Sequencing Key Company Head office and Area Served
  4. 3.4 Global Prenatal Second-Generation DNA Sequencing Company, Product Type & Application
  5. 3.5 Global Prenatal Second-Generation DNA Sequencing Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Prenatal Second-Generation DNA Sequencing Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Prenatal Second-Generation DNA Sequencing Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Prenatal Second-Generation DNA Sequencing Tier 1, Tier 2, and Tier 3
4 Prenatal Second-Generation DNA Sequencing Market by Type
  1. 4.1 Global Prenatal Second-Generation DNA Sequencing Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Prenatal Second-Generation DNA Sequencing Market Size by Type (2021-2032)
  3. 4.3 Global Prenatal Second-Generation DNA Sequencing Market Size Share by Type (2021-2032)
5 Prenatal Second-Generation DNA Sequencing Market by Application
  1. 5.1 Global Prenatal Second-Generation DNA Sequencing Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Prenatal Second-Generation DNA Sequencing Market Size by Application (2021-2032)
  3. 5.3 Global Prenatal Second-Generation DNA Sequencing Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Natera
  2. 6.1.1 Natera Company Information
  3. 6.1.2 Natera Business Overview
  4. 6.1.3 Natera Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Natera Prenatal Second-Generation DNA Sequencing Product Portfolio
  6. 6.1.5 Natera Recent Developments
  7. 6.2 Labcorp
  8. 6.2.1 Labcorp Company Information
  9. 6.2.2 Labcorp Business Overview
  10. 6.2.3 Labcorp Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Labcorp Prenatal Second-Generation DNA Sequencing Product Portfolio
  12. 6.2.5 Labcorp Recent Developments
  13. 6.3 Quest Diagnostics
  14. 6.3.1 Quest Diagnostics Company Information
  15. 6.3.2 Quest Diagnostics Business Overview
  16. 6.3.3 Quest Diagnostics Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Quest Diagnostics Prenatal Second-Generation DNA Sequencing Product Portfolio
  18. 6.3.5 Quest Diagnostics Recent Developments
  19. 6.4 MedGenome
  20. 6.4.1 MedGenome Company Information
  21. 6.4.2 MedGenome Business Overview
  22. 6.4.3 MedGenome Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 MedGenome Prenatal Second-Generation DNA Sequencing Product Portfolio
  24. 6.4.5 MedGenome Recent Developments
  25. 6.5 Mayo Clinic Laboratories
  26. 6.5.1 Mayo Clinic Laboratories Company Information
  27. 6.5.2 Mayo Clinic Laboratories Business Overview
  28. 6.5.3 Mayo Clinic Laboratories Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Mayo Clinic Laboratories Prenatal Second-Generation DNA Sequencing Product Portfolio
  30. 6.5.5 Mayo Clinic Laboratories Recent Developments
  31. 6.6 GeneDx
  32. 6.6.1 GeneDx Company Information
  33. 6.6.2 GeneDx Business Overview
  34. 6.6.3 GeneDx Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 GeneDx Prenatal Second-Generation DNA Sequencing Product Portfolio
  36. 6.6.5 GeneDx Recent Developments
  37. 6.7 PreventionGenetics
  38. 6.7.1 PreventionGenetics Company Information
  39. 6.7.2 PreventionGenetics Business Overview
  40. 6.7.3 PreventionGenetics Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 PreventionGenetics Prenatal Second-Generation DNA Sequencing Product Portfolio
  42. 6.7.5 PreventionGenetics Recent Developments
  43. 6.8 SYNLAB
  44. 6.8.1 SYNLAB Company Information
  45. 6.8.2 SYNLAB Business Overview
  46. 6.8.3 SYNLAB Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 SYNLAB Prenatal Second-Generation DNA Sequencing Product Portfolio
  48. 6.8.5 SYNLAB Recent Developments
  49. 6.9 Myriad Genetics
  50. 6.9.1 Myriad Genetics Company Information
  51. 6.9.2 Myriad Genetics Business Overview
  52. 6.9.3 Myriad Genetics Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Myriad Genetics Prenatal Second-Generation DNA Sequencing Product Portfolio
  54. 6.9.5 Myriad Genetics Recent Developments
  55. 6.10 GGA
  56. 6.10.1 GGA Company Information
  57. 6.10.2 GGA Business Overview
  58. 6.10.3 GGA Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 GGA Prenatal Second-Generation DNA Sequencing Product Portfolio
  60. 6.10.5 GGA Recent Developments
  61. 6.11 Fulgent Genetics
  62. 6.11.1 Fulgent Genetics Company Information
  63. 6.11.2 Fulgent Genetics Business Overview
  64. 6.11.3 Fulgent Genetics Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Fulgent Genetics Prenatal Second-Generation DNA Sequencing Product Portfolio
  66. 6.11.5 Fulgent Genetics Recent Developments
  67. 6.12 Rainbow Genomics
  68. 6.12.1 Rainbow Genomics Company Information
  69. 6.12.2 Rainbow Genomics Business Overview
  70. 6.12.3 Rainbow Genomics Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Rainbow Genomics Prenatal Second-Generation DNA Sequencing Product Portfolio
  72. 6.12.5 Rainbow Genomics Recent Developments
  73. 6.13 BillionToOne
  74. 6.13.1 BillionToOne Company Information
  75. 6.13.2 BillionToOne Business Overview
  76. 6.13.3 BillionToOne Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 BillionToOne Prenatal Second-Generation DNA Sequencing Product Portfolio
  78. 6.13.5 BillionToOne Recent Developments
  79. 6.14 BGI Genomics
  80. 6.14.1 BGI Genomics Company Information
  81. 6.14.2 BGI Genomics Business Overview
  82. 6.14.3 BGI Genomics Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 BGI Genomics Prenatal Second-Generation DNA Sequencing Product Portfolio
  84. 6.14.5 BGI Genomics Recent Developments
  85. 6.15 Berry Genomics
  86. 6.15.1 Berry Genomics Company Information
  87. 6.15.2 Berry Genomics Business Overview
  88. 6.15.3 Berry Genomics Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Berry Genomics Prenatal Second-Generation DNA Sequencing Product Portfolio
  90. 6.15.5 Berry Genomics Recent Developments
  91. 6.16 Annaroad
  92. 6.16.1 Annaroad Company Information
  93. 6.16.2 Annaroad Business Overview
  94. 6.16.3 Annaroad Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 Annaroad Prenatal Second-Generation DNA Sequencing Product Portfolio
  96. 6.16.5 Annaroad Recent Developments
  97. 6.17 Weihansi Biomedical Technology
  98. 6.17.1 Weihansi Biomedical Technology Company Information
  99. 6.17.2 Weihansi Biomedical Technology Business Overview
  100. 6.17.3 Weihansi Biomedical Technology Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 Weihansi Biomedical Technology Prenatal Second-Generation DNA Sequencing Product Portfolio
  102. 6.17.5 Weihansi Biomedical Technology Recent Developments
7 North America
  1. 7.1 North America Prenatal Second-Generation DNA Sequencing Market Size (2021-2032)
  2. 7.2 North America Prenatal Second-Generation DNA Sequencing Market Size by Type
  3. 7.2.1 North America Prenatal Second-Generation DNA Sequencing Market Size by Type (2021-2026)
  4. 7.2.2 North America Prenatal Second-Generation DNA Sequencing Market Size by Type (2027-2032)
  5. 7.2.3 North America Prenatal Second-Generation DNA Sequencing Market Share by Type (2021-2032)
  6. 7.3 North America Prenatal Second-Generation DNA Sequencing Market Size by Application
  7. 7.3.1 North America Prenatal Second-Generation DNA Sequencing Market Size by Application (2021-2026)
  8. 7.3.2 North America Prenatal Second-Generation DNA Sequencing Market Size by Application (2027-2032)
  9. 7.3.3 North America Prenatal Second-Generation DNA Sequencing Market Share by Application (2021-2032)
  10. 7.4 North America Prenatal Second-Generation DNA Sequencing Market Size by Country
  11. 7.4.1 North America Prenatal Second-Generation DNA Sequencing Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Prenatal Second-Generation DNA Sequencing Market Size by Country (2021-2026)
  13. 7.4.3 North America Prenatal Second-Generation DNA Sequencing Market Size by Country (2027-2032)
  14. 7.4.4 North America Prenatal Second-Generation DNA Sequencing Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Prenatal Second-Generation DNA Sequencing Market Size (2021-2032)
  2. 8.2 Europe Prenatal Second-Generation DNA Sequencing Market Size by Type
  3. 8.2.1 Europe Prenatal Second-Generation DNA Sequencing Market Size by Type (2021-2026)
  4. 8.2.2 Europe Prenatal Second-Generation DNA Sequencing Market Size by Type (2027-2032)
  5. 8.2.3 Europe Prenatal Second-Generation DNA Sequencing Market Share by Type (2021-2032)
  6. 8.3 Europe Prenatal Second-Generation DNA Sequencing Market Size by Application
  7. 8.3.1 Europe Prenatal Second-Generation DNA Sequencing Market Size by Application (2021-2026)
  8. 8.3.2 Europe Prenatal Second-Generation DNA Sequencing Market Size by Application (2027-2032)
  9. 8.3.3 Europe Prenatal Second-Generation DNA Sequencing Market Share by Application (2021-2032)
  10. 8.4 Europe Prenatal Second-Generation DNA Sequencing Market Size by Country
  11. 8.4.1 Europe Prenatal Second-Generation DNA Sequencing Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Prenatal Second-Generation DNA Sequencing Market Size by Country (2021-2026)
  13. 8.4.3 Europe Prenatal Second-Generation DNA Sequencing Market Size by Country (2027-2032)
  14. 8.4.4 Europe Prenatal Second-Generation DNA Sequencing Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Prenatal Second-Generation DNA Sequencing Market Size (2021-2032)
  2. 9.2 China Prenatal Second-Generation DNA Sequencing Market Size by Type
  3. 9.2.1 China Prenatal Second-Generation DNA Sequencing Market Size by Type (2021-2026)
  4. 9.2.2 China Prenatal Second-Generation DNA Sequencing Market Size by Type (2027-2032)
  5. 9.2.3 China Prenatal Second-Generation DNA Sequencing Market Share by Type (2021-2032)
  6. 9.3 China Prenatal Second-Generation DNA Sequencing Market Size by Application
  7. 9.3.1 China Prenatal Second-Generation DNA Sequencing Market Size by Application (2021-2026)
  8. 9.3.2 China Prenatal Second-Generation DNA Sequencing Market Size by Application (2027-2032)
  9. 9.3.3 China Prenatal Second-Generation DNA Sequencing Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Prenatal Second-Generation DNA Sequencing Market Size (2021-2032)
  2. 10.2 Asia Prenatal Second-Generation DNA Sequencing Market Size by Type
  3. 10.2.1 Asia Prenatal Second-Generation DNA Sequencing Market Size by Type (2021-2026)
  4. 10.2.2 Asia Prenatal Second-Generation DNA Sequencing Market Size by Type (2027-2032)
  5. 10.2.3 Asia Prenatal Second-Generation DNA Sequencing Market Share by Type (2021-2032)
  6. 10.3 Asia Prenatal Second-Generation DNA Sequencing Market Size by Application
  7. 10.3.1 Asia Prenatal Second-Generation DNA Sequencing Market Size by Application (2021-2026)
  8. 10.3.2 Asia Prenatal Second-Generation DNA Sequencing Market Size by Application (2027-2032)
  9. 10.3.3 Asia Prenatal Second-Generation DNA Sequencing Market Share by Application (2021-2032)
  10. 10.4 Asia Prenatal Second-Generation DNA Sequencing Market Size by Country
  11. 10.4.1 Asia Prenatal Second-Generation DNA Sequencing Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Prenatal Second-Generation DNA Sequencing Market Size by Country (2021-2026)
  13. 10.4.3 Asia Prenatal Second-Generation DNA Sequencing Market Size by Country (2027-2032)
  14. 10.4.4 Asia Prenatal Second-Generation DNA Sequencing Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Prenatal Second-Generation DNA Sequencing Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Prenatal Second-Generation DNA Sequencing Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Prenatal Second-Generation DNA Sequencing Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Prenatal Second-Generation DNA Sequencing Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Prenatal Second-Generation DNA Sequencing Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Prenatal Second-Generation DNA Sequencing Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Prenatal Second-Generation DNA Sequencing Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Prenatal Second-Generation DNA Sequencing Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Prenatal Second-Generation DNA Sequencing Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Prenatal Second-Generation DNA Sequencing Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Prenatal Second-Generation DNA Sequencing Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Prenatal Second-Generation DNA Sequencing Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Prenatal Second-Generation DNA Sequencing Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Prenatal Second-Generation DNA Sequencing Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst